What is an MFN clause in a SAFE and how can it come back to bite me?
The short answer
A Most Favored Nation clause lets an early SAFE investor automatically get the best terms you give any later SAFE investor, so if you raise the next cheque at a lower cap, that better cap flows backward to them. This is fair protection for someone who took early risk, but if you sign several MFN SAFEs and later cut a sweeter deal, you can silently re-price all of them and lose more equity than planned. Track every MFN you've granted and model the worst case before you offer a friendlier term to anyone new.
Go deeper, your way
3 hand-picked resources, 3 link-checked. Pick how you want to dig in.
📄 Article
✓ Link checkedFreeIntermediate
Why we picked it
This is the one piece that does both jobs you need. It runs the exact worked backward-repricing case (three angels on no-cap MFN SAFEs, later a pre-seed at an $8M cap, and their combined stake jumps from 4.2% to 6.25%), then hands you a four-step audit: identify every instrument with MFN language before you raise again, model conversion assuming all MFN holders elect the lowest cap you plan to issue, disclose MFNs during term-sheet talks, and standardize future SAFEs at the same cap on the same day. That last rule is the practical fix most founders miss.
A no-cap MFN SAFE is not a free option: the moment you give a later investor a real cap, that cap flows backward and can swing your MFN holders' ownership by 2 to 4 points, absorbed almost entirely by founders
Before any new raise, audit the cap table for every MFN and model the worst case where all of them elect the lowest cap you intend to offer, not the cap you hope to hold
Cap MFN exposure structurally with a sunset (12 to 18 months) and by issuing all early SAFEs at one cap on one day, so a single later concession cannot re-price a whole tranche
Why we picked it
Kruze does startup finance and cap tables for a living, so this is the operator's take rather than a lawyer's summary. It shows the trap in one line: offer a $15M cap first, later grant a $9M cap to close a hard investor, and your MFN investors follow that $9M cap while your dilution runs well past your model. Its fix is concrete: build a simple cap-table model with multiple SAFE tranches, keep your cap-table software aligned with the actual signed documents, and limit MFN scope to cap and discount rather than every investor-favorable right.
An uncapped MFN-only SAFE quietly hands the early investor whatever your best future cap turns out to be, so treat it as a floating claim on your best terms, not a placeholder
Scope the MFN in the document itself to just cap and discount, otherwise later rights you grant anyone can leak back to earlier investors too
Keep your cap-table tool reconciled to the actual signed SAFEs; a model that ignores MFN language will understate your true post-conversion dilution
Why we picked it
EquityList runs cap tables and ESOP admin for Indian startups, so this places MFN inside the instrument choices an Indian founder actually faces. It states the mechanic cleanly (if a future SAFE gets a lower cap or bigger discount, MFN holders can adopt it) and, crucially, frames the India reality: SAFEs are not native to Indian company law, so you are usually running convertible notes (DPIIT-recognized startup, minimum 25 lakh cheque), where the same most-favored logic applies to the cap and discount you can later offer.
In India you are typically issuing convertible notes, not US SAFEs (DPIIT recognition and a 25 lakh minimum apply), but the MFN backward-repricing risk on cap and discount carries over unchanged
MFN means any better term you later grant can be claimed by earlier holders, which directly narrows the room you have to sweeten a bridge or close a reluctant investor
Read every early instrument's conversion mechanics side by side before your next raise, because MFN plus pro-rata rights compound founder dilution when they all converge on the most protective terms
